Liver Health and Toxicology Research Center
Hepatobiology and Toxicology COBRE
This center at the University of Louisville explores new ways to understand and treat various liver diseases, including those caused by alcohol, fatty liver, and environmental factors.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisville NIH-funded |
| Lab location | 1 site (Louisville, United States) |
| Project ID | NIH-11059099 on NIH RePORTER |
What this research studies
Our center at the University of Louisville is dedicated to understanding how different liver diseases develop and finding better ways to treat them. We focus on common conditions like non-alcoholic fatty liver disease, alcoholic liver disease, and liver injury from environmental toxins or medications. By bringing together experienced and new researchers, we aim to uncover the root causes of these problems. Our goal is to discover new prevention and treatment strategies that could significantly improve patient care for a wide range of liver conditions.
Who could benefit from this research
Good fit: Patients with various liver conditions, including fatty liver disease, alcoholic liver disease, and drug-induced liver injury, could potentially benefit from future treatments developed through this research.
Not a fit: Patients whose conditions are unrelated to liver diseases or who are not affected by the specific types of liver injury being studied may not directly benefit from this particular research.
Why it matters
Potential benefit: If successful, this research could lead to new ways to prevent and treat various liver diseases, improving health outcomes for many patients.
How similar studies have performed: This center builds upon existing knowledge in liver research, bringing together diverse expertise to address critical gaps in understanding and treatment.
Where this research is happening
Louisville, United States
- University of Louisville — Louisville, United States (Active)
Researchers
- Principal investigator: Mcclain, Craig J. — University of Louisville
- Study coordinator: Mcclain, Craig J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.